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Abstract
Background: Methamphetamine (MA) remains one of the most commonly used amphetamine-type stimulants,
accounting for the second most widely-used substance after marijuana. Due to increased use of MA, a wide variety
of research has focused on the patterns of MA use initiation among adolescents. Nevertheless, there are few data
available for people who use MA. The present study set out to assess the sequential patterns of substance use
initiation in patients with MA use disorders in Iran.
Materials and methods: This cross-sectional study described substance initiation patterns for 302 patients who
used MA admitted to hospitals and psychiatric centers of Shiraz University of Medical Sciences. The study was
conducted between April 2015 and June 2016. After obtaining informed consents, participants were interviewed by
trained interviewers using face-to-face, semi-structured interviews. The collecting data were analyzed using the chi
square tests and one-way analysis of variance (ANOVA) tests to compare the relationship between qualitative and
quantitative variables, respectively.
Results: Out of 302 participants enrolled in the study, 16 (5.3%) and 286 (94.7%) were female and male,
respectively. The mean age of participants in the study was 37.29 years. The mean age of onset of MA use was
found to be 15.9 years. 46.1% of the patients started MA use before 15 years. 77.2% of the patients who used MA
had family members with a history of substance use. 93.71% of the patients who used MA started substance use
with tobacco, alcohol, or opium, as the most frequent substances. Tobacco, as the first substance or starting
substance, exhibited the most widely-used substance (69.53% of the cases). Tobacco-alcohol-cannabis-opium-
heroin-MA sequencing was significantly related to the early onset of the substance use. Early-onset substance use
was significantly higher in those with lower income, primary education, and family history of substance use. No
significant relationship was found between employment status with the age of onset of substance use, and
different substance use with marital status.
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Conclusion: Tobacco, alcohol and opium can be considered as the main sequencing substances for initiation to
MA use. Standardized measures to decrease and control access to main starting and sequencing substances,
including tobacco, alcohol, and opium, can greatly help decrease the early onset of the MA use, develop suitable
prevention, and establish early intervention strategies.
Keywords: Methamphetamine (MA), Methamphetamine use patterns, Methamphetamine use initiation, Substance
sequences
Introduction
Amphetamines, as sympathomimetics and psychostimu-
lants, are the most commonly-used drugs after cannabis
in the UK, Australia, and several Western European
countries. Methamphetamine (MA), a potent form of
amphetamine first made in 1893 by Japanese researcher
Nagai Nagayoshi 6 years after the discovery of amphet-
amine, has been one of the most commonly used
amphetamine-like drugs in recent years [1]. MA is a
highly addictive and euphoric stimulant, representing
one of the largest illegal drugs in the world which has
become more prevalent than other amphetamine deriva-
tives [2, 3]. Generally, the use of amphetamine-like stim-
ulants, including MA, is a major concern, representing
the second most commonly used substance after
marijuana according to the United Nations Office on
Drugs and Crime [2]. In the United States, the number
of patients who use MA increased from 353,000 in 2010
to 569,000 in 2014 [4].
MA is used through a variety of routes, including inhal-
ation, smoking, intravenous injection, and oral intake [4].
This white crystalline drug is absorbed quickly from the
mouth and its effects usually appear within an hour after in-
gestion [2]. MA releases and inhibits the reabsorption of
serotonin, norepinephrine, and dopamine. The high levels of
such neurotransmitters in synapses lead to euphoria, insom-
nia, increased libido as well as increased energy for a longer
time. Short-term adverse effects include increased blood
pressure, heart rate and respiratory rate, chest pain, de-
creased appetite, anorexia, restlessness, confusion, tremor,
seizure, anxiety, aggression, and symptoms of psychosis, in-
cluding delusions and paranoia. Because of its ready avail-
ability, inexpensiveness and reinforcing properties, the
chronic use of MA can have serious and potentially danger-
ous consequences [5].
MA is a heavily-abused substance with an estimated
24 million users worldwide, indicating a serious and
growing public health issue in a variety of countries [6].
Although decreasing significantly from ∼ 35 million in
2005, the prevalence of MA use has increased in Europe
and Asia, in countries such as the Netherlands, China,
India, and Iran [6–8]. Of note, Iran faces with a higher
rate of substance use as compared with many countries
in the world, so that the rate of substance use has tripled
in Iran in recent years as compared with the rate of
population growth [9–13]. Although opium and canna-
bis are considered as traditional drugs of abuse in Iran,
the use of heroin, crystal, ecstasy, and MA has increased
in recent years [14]. In 2010, the Persian police reported
a 50% decrease and 54% increase in seizing opiates and
MA, respectively, as compared with 2009 [15]. It is esti-
mated that there are 1.2–2 million users who are
dependent on illicit drugs mainly opiates and MA. Epi-
demiological studies revealed the prevalence of MA use
in 7, 73.9 and 13.3% of the adults in the general popula-
tion of Tehran [16], truck drivers across the country [17]
and male bodybuilders in Tehran [18], respectively. In-
creased physical energy, wakefulness, pleasure-seeking
and professional performance were found to be the main
reasons for MA use [15]. Analyses of substance use initi-
ation and sequencing patterns may help find risk factors
for other behaviors.
Considering the increased prevalence of the stimulant
use such as MA in Iran, there is an urgent need to study
the sequence and profile of substance use before MA
use in Iran. Therefore, the present study was tailored to
evaluate the sequential patterns of substance use initi-
ation in patients with MA use disorders in Iran.
Materials and methods
Ethics statement
This study was carried out in accordance with the recom-
mendations of ethical guidelines, IR.SUMS.REC.1394.S1206.
The research protocol was approved by Shiraz University of
Medical Sciences. All subjects were given written informed
consent in accordance with the Declaration of Helsinki.
Design
This cross-sectional study was conducted between April
2015 and June 2016 to investigate the substance use in the
patients who used MA and to find the sequential patterns of
MA use. Our sample consisted of all patients who used MA
admitted to hospitals and psychiatric hospitals affiliated to
Shiraz University of Medical Sciences, including Ibn-e-Sina
Psychiatric Educational Hospital, Hafez Educational Hos-
pital, and Recovery Center during the study period.
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Participants
In the centers that the samples were collected, all the
people used substances and almost all the patients used
MA. Interviews were conducted by a psychologist or as-
sistant psychologist. The participants were evaluated at
one-time point by face-to-face, semi-structured inter-
views for approximately 20–30min. Those patients who
met DSM5 diagnostic criteria for MA use disorders were
included in the study. Only a small number of the pa-
tients who did not meet these criteria were excluded
from the study (such as those who did not sign the con-
sent form or lacked a good memory). In total, 302 pa-
tients (95% confidence coefficient and 5% error and
alpha = 0.05) were participated in this study. The study
followed the Strengthening the Reporting of Observa-
tional Studies in Epidemiology (STROBE) guidelines [19]
to strengthen the methodology and report of the
findings.
Inclusion criteria
Potential participants were eligible for the study if they
met the following inclusion criteria:
 Age between 18 and 65 years old
 MA use over the past year based on DSM5 criteria
 DSM5 criteria for MA use disorders
Exclusion criteria
Patients were excluded from the study if they met one of
the following exclusion criteria:
 People with cognitive impairment, severe aggression,
and psychosis who were unable to cooperate in the
interview and whose information was not sufficiently
reliable at the time of the interview
 Discontent to participate in the study
Procedure
After obtaining written informed consent, qualified pa-
tients were interviewed and the required information
was collected on the basis of a pre-prepared checklist.
In-person interview checklist included:
 Demographic information including age, sex, marital
status, occupation, income, and education
 The history of different types of substance use in the
past year
 The age of the first substance use
 The first substance used
 Sequential use of substances from beginning up to
now (to find sequential patterns)
 The history of substance uses in the family, the
number of family members with substance use, and
the type of substances used
 Previous history of admission to Psychiatric Hospital
Substances used were classified according to substance
use and drug classification as follows:
 The tobacco group: including hookah and cigarettes
 The alcohol group: only including alcohol
 The cannabis group: including marijuana and
cannabis
 The opium group: including opium and opium sap
 The heroin group: including heroin and crack
 The cocaine group: only including cocaine
 The Ritalin group: only including Ritalin
 The MA group: only including MA
Sequential profiling
The sequential patterns for MA use were determined
based on the order of substance use in patients who
used MA. In the questionnaire, we asked participants
specifically about the order of the substances that they
used before MA use.
Statistical analysis
The data were evaluated by SPSS software version 20.
The results were analyzed by descriptive statistics, in-
cluding mean ± standard deviation for quantitative vari-
ables and frequency tables for qualitative variables. In
addition, chi-square and one-way analysis of variance
(ANOVA) tests were used to compare the relationship
between qualitative and quantitative variables, respect-
ively. If the result of the ANOVA test was significant, a
least significant difference test was applied to locate
which of the means differed. P values < 0.05 were con-
sidered to be statistically significant.
Results
A total of 302 participants were enrolled in the study.
Table 1 indicates demographic characteristics of the
sample, including gender, age, education, monthly in-
come, age of onset of substance use, history of
hospitalization, the rate of substance use in the family,
type of substances used in the family member, and type
of substances used in the last year. The mean age of par-
ticipants in the study was 37.29 years and the mean age
of onset of substance use was found to be 15.9 years.
Based on the demographic characteristics, participants
were divided into several groups, including the education
level (including three groups, elementary education in-
cluding illiterate and elementary education, secondary
education/high school, and higher educational level in-
cluding diploma and higher education); the monthly in-
come (including three groups, low-income, middle-
income, and high-income); the age of onset of substance
use (including two groups, early and late onset); the
Sarani et al. Substance Abuse Treatment, Prevention, and Policy           (2020) 15:52 Page 3 of 10
Table 1 Demographic characteristics of the study population
Characteristics Number (n = 302) Percent
Gender Male 286 94.7%
Female 16 5.3%
Age (years) 18–40 187 61.7%
Over 40 115 38.3%
Marital status Single 95 31.5%
Married 140 46.3%
Divorced 60 19.9%
Widow 7 2.3%
Employment Unemployed 75 24.8%
Employed 227 75.2%
Self-employed 183 60.6%
Employee 37 12.2%
Retired 5 1.7%
Student 2 0.7%
Educationa Elementary education 55 18.2%
Secondary education 217 71.9%
Higher education 30 9.9%
Monthly income (Tomans) Low (< 500,000) 148 49%
Middle (500,000-2,000,000) 130 43.1%
High (> 2,000,000) 24 7.9%
Age of onset (years) of substance use Early (< 15) 139 46%
Late (> 15) 163 54%
History of hospitalization No 185 61.3%
Yes; previous psychiatric hospitalization 117 38.7%
Substance use in the family No 69 22.8%
Yes 233 77.2%
One member 98 32.4%
Two members 59 19.5%
Three members 34 11.3%
Four members 18 6%
Five members 12 4%
Six members 5 1.7%
Seven members 7 2.3%
Type of substance use in the family members Stimulant substancesb 47 15.6%
Non-stimulant substances 255 84.4%
Type of substance use in the last yearc Tobacco group 290 96%
Heroin group 216 71.5%
Opium group 150 49.7%
Cannabis group 119 39.4%
Alcohol group 97 32.1%
Cocaine group 16 5.3%
Ritalin group 3 1%
aElementary education including illiterate and elementary education; Secondary education including high school education; and Higher education
including diploma and higher education
bStimulant substances including Ritalin, amphetamines and cocaine
cThe tobacco group, including hookah and cigarettes; the heroin group, including heroin and crack; the opium group, including opium and opium sap;
the cannabis group, including marijuana and cannabis; the alcohol group, only including alcohol; the cocaine group, only including cocaine; and the
Ritalin group, only including Ritalin (methylphenidate)
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substance use in the family (including two groups, those
with family members who used substances and did not
use substances); type of substances used in the family
members (including two groups, the family members who
used stimulant substances including Ritalin, amphet-
amines and cocaine, and the family members who used
non-stimulant substances); the substance type in the last
year (the tobacco group including hookah and cigarette,
heroin group including heroin and crack, opium group in-
cluding opium and sap, cannabis group including
marijuana and cannabis, alcohol group only including al-
cohol, cocaine group only including cocaine, and Ritalin
group only including Ritalin (methylphenidate)).
As shown in Fig. 1, tobacco, as the first substance or
starting substance, exhibited the most widely-used sub-
stance (69.5% of the cases), showing statistically signifi-
cant differences (p ≤ 0.0001). After tobacco, 13.6 and
10.6% of the patients who used MA started substance
use with alcohol and opium, respectively, showing statis-
tically significant differences (p ≤ 0.0001). Other sub-
stances used included cannabis (3.3%), heroin (1.7%),
and MA (1%), respectively. Only one case (0.3%) men-
tioned Ritalin as the first substance and no one (0%)
started substance use with cocaine; in total, 93.71% of
the patients who used MA started substance use with to-
bacco, alcohol, or opium.
The comparison between heroin and MA use showed
that 41 of the patients who used MA started with MA
earlier than heroin (13.58% of all the patients who used
MA and 17.7% of the patients who used both heroin and
MA). In contrast, 190 of the patients who used MA
started with heroin earlier than MA (62.91% of all the
patients who used MA and 82% of the patients who used
both heroin and MA).
The comparison between cannabis and opium use dem-
onstrated that 92 of the patients who used MA started
with cannabis earlier than opium (30.46% of all the pa-
tients who used MA and 56.72% of the patients who used
both cannabis and opium). In contrast, 70 of the patients
who used MA started with opium earlier than cannabis
(23.18% of all the patients who used MA and 43.2% of the
patients who used both cannabis and opium).
The comparison between cannabis and tobacco use re-
vealed that 167 of the patients who used MA started
with tobacco earlier than cannabis (55.30% of all the pa-
tients who used MA and 93.29% of the patients who
used both cannabis and tobacco). In contrast, 12 of the
patients who used MA started with cannabis earlier than
tobacco (3.97% of all the patients who used MA and
6.07% of the patients who used both cannabis and
tobacco).
The comparison between alcohol and tobacco use in-
dicated that 154 of the patients who used MA started
with tobacco earlier than alcohol (50.99% of all the pa-
tients who used MA and 80.2% of the patients who used
both alcohol and tobacco). In contrast, 38 of the patients
who used MA started with alcohol earlier than tobacco
(12.58% of all the patients who used MA and 19.79% of
the patients who used both alcohol and tobacco).
The comparison between alcohol and opium use
showed that 136 of the patients who used MA started
with alcohol earlier than opium (45.03% of all the pa-
tients who used MA and 73.91% of the patients who
used both alcohol and opium). In contrast, 48 of the
patients who used MA started with opium earlier
than alcohol (15.89% of all the patients who used MA
and 26.08% of the patients who used both alcohol
and opium).
Fig. 1 Frequency of the first substance used among the patients who used methamphetamine (MA)
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The comparison between alcohol and cannabis use
showed that 100 of the patients who used MA started
with alcohol earlier than cannabis (33.11% of all the pa-
tients who used MA and 72.99% of the patients who
used both alcohol and cannabis). In contrast, 37 of the
patients who used MA started with cannabis earlier than
alcohol (12.25% of all the patients who used MA and
27% of patients who used both alcohol and cannabis).
A variety of sequencing patterns was obtained in this
study, the most common of which included:
Sequencing D: tobacco-opium-heroin-MA (n = 24).
Sequencing F: tobacco-alcohol-cannabis-opium-her-
oin-MA (n = 20).
Sequencing C: tobacco-opium-MA (n = 19).
Sequencing E: tobacco-alcohol-opium-heroin-MA (n= 17).
Sequencing A: MA (n = 3).
Sequencing B: tobacco-MA (n = 2).
Based on the age of onset of substance use, as men-
tioned above, patients were divided into two groups, in-
cluding early onset and late onset; the comparison
between sequencing patterns and the age of onset of
substance use showed that sequencing F was signifi-
cantly lower than sequencings C, D, and E (Table 2).
The comparison between the age of onset of substance
use and current monthly income showed the number of
patients who used MA with early onset of substance use
was significantly higher in the low-income group (P-
value = 0.006) (Table 3).
The comparison between the age of onset of substance
use and education level showed that the number of pa-
tients who used MA with high education was lower in
the early-onset group, while the number of patients who
used MA with primary education was higher in the
early-onset group. These findings were statistically sig-
nificant (P-value = 0.04).
The comparison between the age of onset of substance
use and the starting substance type showed no signifi-
cant relationship. Table 4 indicates the mean age of pa-
tients who used MA in starting groups with different
substances. The highest and lowest mean age was associ-
ated with MA (30 years) and tobacco (15.25 years) start-
ing groups, respectively.
The comparison between substance use in the family
and different sequences of substance use showed a
higher rate of odds ratio (OR) for sequencing C, as a re-
sult of which early onset of substance use was correlated
with family member uses. In other words, patients who
used MA with family history of substance use started
MA use earlier than others.
The comparison between different sequences of sub-
stance use and the number of family members who used
substances showed that only sequencing F were statisti-
cally significant (P value = 0.03) (Table 5). The family
history of substance use was found to be a risk factor for
sequencing F (OR = 0.8).
The relationship between the use of stimulants in the
family, including cocaine, MA, and Ritalin, showed no
significant difference between sequences and use of
stimulants in the family. No significant relationship was
found between employment status and the age of onset
of substance use as well as between different substance
use and marital status.
Discussion
A number of studies have investigated the sequence of
substance use initiation [20–23], suggesting that initi-
ation of a substance and the sequence patterns of the
substance use may be a risk factor for other behaviors.
Fewer studies have investigated the sequence of sub-
stance use initiation for MA. The present study evalu-
ated the sequential patterns of substance use before MA
use disorders in Iran.
Our findings showed early onset of MA use in Iran.
This early-onset MA use was significantly higher in
those with lower income, primary education, no history
of hospitalization, and family history of substance use.
Tobacco followed by alcohol and opium, as starting sub-
stances, was found to be an important risk factor for
MA use disorders. Sequencing D (tobacco-opium-her-
oin-MA) was the most common sequencing pattern in
patients who used MA. Sequencing F (tobacco-alcohol-
cannabis-opium-heroin-MA) was significantly related to
the early onset of MA use.
The abuse of substances, including MA, is associated
with substantial costs and limited treatment options. Re-
searches on the patterns and sequences of substance ini-
tiation provide a far more comprehensive portrait to
develop suitable prevention and early intervention
strategies.
In the present study, tobacco, followed by alcohol and
opium, was found to be the first substance or starting
substance used in patients with MA use, serving as a
Table 2 Relationship between different sequencing patterns and age of onset of substance use
Sequence C (n = 19)a D (n = 24)a E (N = 17)a F (N = 20)b *P-value
Age started (mean ± SD) 16.15 ± 4.34 17.04 ± 4.92 17 ± 3.77 12.05 ± 3.94 < 0.0001
C (sequencing C): tobacco-opium-MA; D (sequencing D), tobacco-opium-heroin-MA; E (sequencing E): tobacco-alcohol-opium-heroin-MA; and F (sequencing
F), tobacco-alcohol-cannabis-opium-heroin-MA.
MA methamphetamine
Dissimilar values (superscripts a and b) of each row are significantly different.
*Values were analyzed by one-way analysis of variance (ANOVA); values are mean ± SD
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starting substance for initiation to MA use. Tobacco, alco-
hol and opium accounted for 93.71% of the first sub-
stances used by patients who used MA participated in this
study. In a study carried out by Yen et al. in Taiwan,
cigarette was found to be the most commonly used sub-
stance, and most adolescents had used cigarette, alcohol,
areca quid, and glue before MA use [24]. No differences
were found between cigarette smoking and alcohol use in
their study with the present study; however, glue and
areca quid are not used in Iran. In a study performed by
Brecht et al. in California, tobacco, alcohol, and marijuana
were found as a sequencing pattern for MA use in 95%
cases [9]. The difference between marijuana and opium
use seems to be due to the prevalence of opium use in
Iran. Only 3 patients who used MA started with MA use
(0.99%) in this study, which was consistent with the study
conducted by Brecht et al. in California [9].
Prevalence of substance use in the last year was as
follows:
1. The tobacco group, including hookah and
cigarettes: 96% of the patients who used MA
2. The heroin group, including heroin and crack:
71.6% of the patients who used MA
3. The opium group, including opium and opium sap:
49.7% of the patients who used MA
4. The cannabis group, including marijuana and
cannabis: 39.3% of the patients who used MA
5. The alcohol group, only including alcohol: 32.1% of
the patients who used MA
6. The cocaine group, only including cocaine: 5.3% of
the patients who used MA
7. The Ritalin group, only including Ritalin
(methylphenidate): 1% of the patients who used MA
The prevalence of substance use in the past year was
similar to that found in the study carried out by Darke
et al.in 2012 [10].
In this study, 46.1% of the people who used MA
started before 15 years, while 53.9% of them started MA
use after 15 years; the mean age of onset of the first sub-
stance use was 15.9 years. In the study carried out in
Taiwan, 71% of the patients who used MA used sub-
stances after 15 years of age [24]; the reason for this dif-
ference can be attributed to the cohort effect, because
the study of Yen et al. in Taiwan was carried out in 2005
while our study was performed in 2016, and the age of
onset of substance use decreases over time. In a study
conducted by Darke et al.in Australia [10], the mean age
of the onset of substance use was 14 years, which was
consistent with our findings.
Commonly-used sequencing patterns obtained in this
study included D (tobacco-opium-heroin-MA; n = 24), F
(tobacco-alcohol-cannabis-opium-heroin-MA; n = 20), C
(tobacco-opium-MA; n = 19), E (tobacco-alcohol-opium-
heroin-MA; n = 17), A (MA; n = 3), and B (tobacco-MA;
n = 2), respectively. Common sequencing patterns ob-
tained in the study carried out by Yen et al. in Taiwan
[24] included MA as an initiator (n = 12), cigarette-MA
(n = 86), cigarette-areca quid-MA (n = 41), cigarette-
alcohol-MA (n = 39), alcohol-cigarette-MA (n = 12),
cigarette-areca quid-alcohol-MA (n = 39), cigarette-
alcohol-areca quid-MA (n = 39), and alcohol-cigarette-
areca quid-MA (n = 9). The difference between the se-
quence patterns can be attributed to the high prevalence
of opioid use in Iran and the high prevalence of other
substances such as Areca quid in Taiwan. However, the
first 4 sequencing patterns showing high prevalence
started with cigarettes both in the present study and in
the study conducted in Taiwan [24].
Most patients who used MA participated in this study
used heroin before MA (82%), but in the study carried out
in Taiwan [24], none of the patients who used MA used
heroin before MA, which could be due to the difference in
the age of patients who used MA. In the study carried out
in Taiwan [24], patients who used MA participated in that
study were adolescents with 19 years or younger. In
addition, previous studies showed that heroin is generally
used in older adults [25]. Importantly, there are studies
showing that the tendency to use different substances
changes at different times and in different societies.
The comparison between the sequencing patterns of
tobacco and cannabis use indicated that most patients
Table 3 Relationship between the age of onset of substance use and monthly income
Monthly income Low-income Middle-income High-income Chi-square Df *P-value
Early onset 76 44 19 10.146 2 0.006
Late onset 67 81 15
* The chi-square test was used for the statistical differences
Table 4 The mean age of patients who used MA in starting
groups
First Substance Mean ± SD
Opium 18.06 ± 7.41
Methamphetamine 30 ± 14.93
Cannabis 16.54 ± 4.03
Heroin 19.83 ± 9.78
Alcohol 15.79 ± 4.92
Tobacco 15.25 ± 4.26
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who used MA (93.29%) used tobacco earlier than canna-
bis, which was consistent with the study conducted by
Darke et al. in Australia [10]. Inconsistent with these
findings, the study conducted with Brecht et al. in Cali-
fornia [9] showed that tobacco, marijuana, and alcohol
acted as a sequential substance to MA use, in which al-
cohol was the most frequent substance to be used. This
can be attributed to the frequency of alcohol availability
and use as well as the increasing prevalence of marijuana
use in recent years [26].
The comparison between the sequencing patterns and the
age of onset of substance use showed that sequencing F (to-
bacco-alcohol-cannabis-opium-heroin-MA) was significantly
related to early onset of substance use. This means that pa-
tients who used MA with lower age of onset used more sub-
stances before starting MA use. This finding was consistent
with the studies carried out in Taiwan [24] and Australia
[10], demonstrating that early onset of substance use has
been associated with poly-drug abuse in the future.
In this study, there was a significant relationship be-
tween early onset of substance use and education; early
onset of substance use was found in the patients who
used MA with low educational levels while late onset of
substance use was found in those with higher educa-
tional levels. In a study performed by Russell et al., a sig-
nificant relationship was found between MA use and
lower education, showing that patients who used MA
generally had a lower education level [5]. The highest
and lowest mean ages of onset of substance use were
found to be 30 and 15.25 years in patients who used MA
and tobacco, respectively; the mean ages of onset of
opium, cannabis, alcohol, and heroin use were 18.68,
16.44, 15.59, and 19.83 years old, respectively. The mean
ages of onset found in this study were lower as com-
pared with the study conducted in California [9], in
which patients who used alcohol had the lowest mean
age, and patients who used heroin, followed by MA, had
the highest mean age. The reason for the higher mean
age of patients who used alcohol in our country and the
present study can be attributed to religious beliefs about
alcohol use.
In the present study, early onset of MA use was associ-
ated with a family history of substance use; in other
words, patients who used MA with a family history of
MA use started MA use earlier than other substances. In
addition, sequencing F was also significantly associated
with the greater number of family members with a his-
tory of substance use. In the studies carried out by Rus-
sell et al. [5] and Svingen et al. in Nebraska [27], a
significant relationship was found between the family
history of substance use and substance use in patients
who used substances. The relationship between a family
history of substance use and the age of onset of sub-
stance use showed that patients who used MA with a
family history of substance use started to use substances
3.8 years earlier [28]; the results from these two studies
were consistent with the results from this study.
The early age of onset of substance use was signifi-
cantly associated with low monthly income. In most
similar studies, the role of income levels was not investi-
gated because those studies have chosen their samples
from adolescents and only one study was presented de-
scriptive income sources. In the study carried out by
Darke et al. in Australia [10], 88, 21, and 7% of the pa-
tients who used MA derived their primary income from
the government, criminal activity, and wages, respect-
ively. In collection, the early age of substance use leads
to less education, in turn resulting in lower-paid jobs.
To the best of our knowledge, this is the first study to
examine the sequencing patterns of MA use, which can be
the basis for future studies. However, the present study had
some potential limitations, including the use of self-
reporting, social desirability, selection bias and the low num-
ber of participants, especially female gender; the latter limita-
tion led to no gender comparisons for variables. Therefore,
the results may limit the generalizability of the results to
some extent.
Conclusions
The present study is the first study to examine the se-
quential patterns of substance use for MA disorders in
Iran. In this study, the early-onset MA use was
Table 5 Relationship between drug sequences and family history of substance use
Sequencing patterns Family members with substance use Family members with no substance use chi-
square
*P-
value
OR
N (%) N (%) N (%)
C 13 (68.42) 6 (31.58) 0.92 0.24 1.14
D 17 (70.83) 7 (29.17) 0.75 0.26 1.109
E 14 (82.35) 3 (17.65) 0.22 0.45 0.94
F 19 (95) 1 (5) 3.81 0.03 0.8
C (sequencing C): tobacco-opium-MA; D (sequencing D), tobacco-opium-heroin-MA; E (sequencing E): tobacco-alcohol-opium-heroin-MA; and F (sequencing
F), tobacco-alcohol-cannabis-opium-heroin-MA.
MA methamphetamine
OR odds ratio
* The chi-square test was used for the statistical differences
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significantly higher in patients who had lower income,
primary education, no history of hospitalization, and
family history of substance use. Tobacco, alcohol and
opium were found to be as a sequential pattern for initi-
ation to MA use.
Tobacco-alcohol-cannabis-opium-heroin-MA sequen-
cing was significantly related to the early onset of the
MA use.
Findings from this study may support targeted preven-
tion efforts and development of more effective interven-
tions. Standardized measures to decrease and control
access to main starting and sequencing substances, in-
cluding tobacco, alcohol, and opium, can not only
greatly help decrease the early onset of the MA use, but
also lead to development of suitable prevention and early
intervention strategies. In addition, programs focusing
on increasing knowledge and changing the attitudes of
adolescents toward drug abuse can assist to prevent MA
use through decreased use of these substances in the so-
ciety. However, because of gender limitations, it is rec-
ommended to include more women users in future
studies in order to make gender comparisons possible.
Abbreviation
MA: Methamphetamine
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